John Fetse
Impact in
Papers in
-
- Antimicrobial Peptides and Activities 2
- Oncology 4
- Cancer Immunotherapy and Biomarkers 2
- Peptidase Inhibition and Analysis 2
- Co-authors
- Kun Cheng (10 shared papers)Zhen Zhao (5 shared papers)Akshay Jain (4 shared papers)Yuanke Li (4 shared papers)Reimmel Kwame Adosraku (3 shared papers)Ashutosh J. Barve (2 shared papers)Yanli Liu (3 shared papers)Li Zhang (1 shared paper)
- Journals
- Advanced Therapeutics (3 papers)Acta Biomaterialia (2 papers)Pharmaceutical Research (2 papers)ACS Applied Materials & Interfaces (1 paper)Trends in Pharmacological Sciences (1 paper)
- Partner nations
- United StatesGhanaSouth Africa
In The Last Decade
John Fetse
14 papers receiving 438 citations
Peers
Comparison fields: 5 of 68
- Drug Discovery 1
- Microbiology 33
- Oncology 103
- Biochemistry 29
- Biomaterials 53
Countries citing papers authored by John Fetse
This map shows the geographic impact of John Fetse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Fetse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Fetse more than expected).
Fields of papers citing papers by John Fetse
This network shows the impact of papers produced by John Fetse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Fetse. The network helps show where John Fetse may publish in the future.
Co-authors
The 25 scholars most cited alongside John Fetse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 116 | |
| 2 | 2023 | 100 | |
| 3 | 2019 | 42 | |
| 4 | 2016 | 41 | |
| 5 | 2022 | 39 | |
| 6 | 2022 | 29 | |
| 7 | 2019 | 27 | |
| 8 | 2014 | 18 | |
| 9 | 2021 | 16 | |
| 10 | 2024 | 6 | |
| 11 | 2016 | 4 | |
| 12 | 2024 | 2 | |
| 13 | 2024 | 2 | |
| 14 | 2019 | 2 | |
| 15 | 2026 | 1 | |
| 16 | 2023 | 0 | |
| 17 | 2025 | 0 |
About John Fetse
John Fetse is a scholar working on Microbiology, Oncology, Biotechnology, Immunology and Molecular Biology, having authored 17 papers that have together received 445 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Chemical Synthesis and Analysis (2 papers), Peptidase Inhibition and Analysis (2 papers), RNA Interference and Gene Delivery (2 papers), Antimicrobial Peptides and Activities (2 papers), COVID-19 Clinical Research Studies (1 paper) and Cancer Research and Treatments (1 paper). The work is most often cited by research in Drug Discovery (1 citation), Microbiology (33 citations), Oncology (103 citations), Biochemistry (29 citations) and Biomaterials (53 citations). John Fetse has collaborated with scholars based in United States, Ghana and South Africa. Frequent co-authors include Kun Cheng, Zhen Zhao, Akshay Jain, Yuanke Li, Reimmel Kwame Adosraku, Ashutosh J. Barve, Yanli Liu, Li Zhang, Wei Jin and Hao Liu. Their work appears in journals such as Advanced Therapeutics, Acta Biomaterialia, Pharmaceutical Research, ACS Applied Materials & Interfaces and Trends in Pharmacological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.